Literature DB >> 10066506

Herpes simplex virus latency and the immune response.

M Daheshia1, L T Feldman, B T Rouse.   

Abstract

Following infection, herpes simplex virus establishes latency in the nervous system and recurrences of lytic replication occur periodically. Molecular events which may determine how virus enters latency, how it is maintained and what occurs during reactivation have been investigated. The role of the immune response in limiting infection of the nervous system, influencing the latent state and removing virus from peripheral sites following reactivation has also been studied.

Entities:  

Mesh:

Year:  1998        PMID: 10066506     DOI: 10.1016/s1369-5274(98)80061-1

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  12 in total

Review 1.  Latency in human immunodeficiency virus type 1 infection: no easy answers.

Authors:  Deborah Persaud; Yan Zhou; Janet M Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.

Authors:  Konasale M Prasad; Shaun M Eack; Matcheri S Keshavan; Robert H Yolken; Satish Iyengar; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

3.  Herpes viruses hedge their bets.

Authors:  Michael P H Stumpf; Zoe Laidlaw; Vincent A A Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

Review 4.  Making the case: married versus separate models of alphaherpes virus anterograde transport in axons.

Authors:  R Kratchmarov; M P Taylor; L W Enquist
Journal:  Rev Med Virol       Date:  2012-07-16       Impact factor: 6.989

5.  Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.

Authors:  S Vollstedt; M Franchini; G Alber; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 6.  Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.

Authors:  Fernanda Giménez; Amol Suryawanshi; Barry T Rouse
Journal:  Prog Retin Eye Res       Date:  2012-08-07       Impact factor: 21.198

7.  Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.

Authors:  Pradeep B J Reddy; Sharvan Sehrawat; Amol Suryawanshi; Naveen K Rajasagi; Sachin Mulik; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2011-10-21       Impact factor: 5.422

Review 8.  Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Authors:  Konasale M Prasad; Annie M M Watson; Faith B Dickerson; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-04-06       Impact factor: 9.306

9.  LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Authors:  Daniel H Zimmerman; Harold Steiner; Roy Carmabula; Eyal Talor; Ken S Rosenthal
Journal:  J Vaccines Vaccin       Date:  2012-09-20

10.  Role of Us9 phosphorylation in axonal sorting and anterograde transport of pseudorabies virus.

Authors:  Radomir Kratchmarov; Matthew P Taylor; Lynn W Enquist
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.